Ozempic and other semaglutide medications have been working wonders in terms of shedding pounds for many people , but a study shows that they're still not as effective as surgery when it comes to weight loss – and it's not even close.

Researchers from New York University (NYU) compared sleeve gastrectomy and gastric bypass operations against semaglutide or tirzepatide. These drugs are known as glucagon-like peptide-1 (GLP-1) receptor agonists, because of the way they mimic the natural GLP-1 hormone, which controls appetite .

Using health records, the team matched people who had taken one of the weight loss drugs with people who had undergone either of the bariatric surgery operations, based on age, body mass index, and blood sugar levels.

The bottom line: people in the su

See Full Page